Jahnavi Srinidhi

Jahnavi Srinidhi

Auto-generated profile, based on publicly available information

Jahnavi Srinidhi

Mannheim Center for Translational Neurosciences, Heidelberg University 1 Division of Neurodegeneration, Department of Neurology, Medical Faculty Mannheim Mannheim, Germany

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2024 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
DBDavid Brenner
David Brenner
KSKirsten Sieverding
Kirsten Sieverding
JSJahnavi Srinidhi
Jahnavi Srinidhi
SZSusanne Zellner
Susanne Zellner
CSChristopher Secker
Christopher Secker
JWJochen H. Weishaupt
Jochen H. Weishaupt
Heterozygous mutations in the TBK1 gene can cause amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The majority of TBK1-ALS/FTD patients carry deleterious loss-of-expression mutations, and it is still unclear which TBK1 function leads to neurodegeneration. We investigated the impact of the pathogenic TBK1 missense variant p.E696K, which does not abolish protein expression, but leads to a selective loss of TBK1 binding to the autophagy adaptor protein and TBK1 substrate optineurin. Using organelle-specific proteomics, we found that in a knock-in mouse model and human iPSC–derived motor neurons, the p.E696K mutation causes presymptomatic onset of autophagolysosomal dysfunction in neurons precipitating the accumulation of damaged lysosomes. This is followed by a progressive, age-dependent motor neuron disease. Contrary to the phenotype of mice with full Tbk1 knock-out, RIPK/TNF-α–dependent hepatic, neuronal necroptosis, and overt autoinflammation were not detected. Our in vivo results indicate autophagolysosomal dysfunction as a trigger for neurodegeneration and a promising therapeutic target in TBK1-ALS/FTD.